重症监护病房肝功能不全患者个体化用药决策

Personalized Medicine Policy for Patients with Hepatic Insufficiency in Intensive Care Units

目的临床药师在重症监护病房参与肝功能不全患者的个体化用药治疗,提供个体化用药监护计划。方法通过查阅重症监护病房常用药物相关文献及药物说明书进行分析整理,对肝功能有影响的药物进行归纳总结。结果与结论临床药师应关注重症监护病房特殊人群的个体化用药方案,尤其对于肝功能不全患者加强药学监护,提供个体化用药服务。

OBJECTIVE To provide information for clinical pharmacists who participate in personalized pharmacotherapy for pa- tients with liver dysfunction in intensive care units （ICU） and perform individualized medication monitoring. METHODS Literatures and instructions for medicines used commonly in ICU and medicines harmful to liver were searched and summarized. RESULTS AND CONCLUSION Clinical pharmacists should focus on personalized medicine therapy for special patients in ICU and provide personal- ized medicine services.